COWEN AND COMPANY, LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 66 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2021$1,069,000
-24.2%
249,215
-46.4%
0.05%
-31.1%
Q2 2021$1,410,000
-17.4%
465,317
-16.4%
0.07%
-36.2%
Q1 2021$1,707,000
+3.3%
556,617
+19.6%
0.12%
-21.6%
Q4 2020$1,652,000
+6.9%
465,317
-11.0%
0.15%
-41.0%
Q3 2020$1,545,000
-80.4%
522,649
-87.9%
0.25%
-80.8%
Q2 2020$7,882,000
+80.2%
4,331,0200.0%1.31%
+30.5%
Q1 2020$4,374,000
+69.9%
4,331,020
+367.6%
1.00%
+348.2%
Q4 2019$2,575,000926,2000.22%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Whitefort Capital Management, LP 11,895,477$24,147,81812.66%
Two Seas Capital LP 8,280,818$16,810,0613.38%
FourWorld Capital Management LLC 1,341,907$2,724,0710.51%
Tejara Capital Ltd 180,077$365,5560.21%
Woodline Partners LP 4,719,903$9,581,4030.11%
Hudson Bay Capital Management LP 8,299,808$16,848,6100.07%
Kepos Capital LP 155,691$3160.06%
Virtus ETF Advisers LLC 40,040$81,2810.05%
Centiva Capital, LP 1,071,705$2,175,5610.05%
Kades & Cheifetz LLC 20,000$40,6000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders